REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pt Pharmasolindo (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Pharmasolindo Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Pharmasolindo is based in Indonesia, with the head office in East Jakarta. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on January 17, 1990. From the latest financial highlights, Pt Pharmasolindo reported a net sales revenue increase of 12.86% in 2024. Its’ total assets recorded a growth of 12.19%.

Headquarters
Kawasan Industri Pulogadung, Jl. Pulokambing Raya Blok II J No. 15
East Jakarta; Jakarta; Postal Code: 13920

Contact Details: Purchase the Pt Pharmasolindo report to view the information.

Website: http://www.pharmasolindo.com

Basic Information
Registered Capital:
Purchase the Pt Pharmasolindo report to view the information.
Financial Auditors:
Purchase the Pt Pharmasolindo report to view the information.
Incorporation Date:
January 17, 1990
Key Executives
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Pharmasolindo report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
12.86%▲
Total Operating Revenue
12.86%▲
Total Assets
12.19%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo